{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:42Z","timestamp":1787023662265,"version":"build-2736575974"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,22]]},"DOI":"10.18632\/oncotarget.7321","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T14:21:19Z","timestamp":1455718879000},"page":"14366-14379","source":"Crossref","is-referenced-by-count":18,"title":["SIRT1 at the crossroads of AKT1 and ER\u03b2 in malignant pleural mesothelioma cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Giulia","family":"Pinton","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Piemonte Orientale \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zonca","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Piemonte Orientale \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangela G.","family":"Manente","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Piemonte Orientale \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cavaletto","sequence":"additional","affiliation":[{"name":"Department of Sciences and Technological Innovation, University of Piemonte Orientale \u201cA. Avogadro\u201d, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Borroni","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Piemonte Orientale \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Daga","sequence":"additional","affiliation":[{"name":"Department of Integrated Oncological Therapies, IRCCS San Martino-IST, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthen V.","family":"Jithesh","sequence":"additional","affiliation":[{"name":"Division of Biomedical Informatics Research, Sidra Medical and Research Center, 26999 Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fennell","sequence":"additional","affiliation":[{"name":"Department of Cancer Studies, Cancer Research UK Leicester Centre, University of Leicester, LE1 7RH Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Nutrition, Karolinska Institutet, S-141 57 Huddinge, Sweden"},{"name":"Karo Bio AB, Novum, S-141 57 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moro","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Piemonte Orientale \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/crj.12028","article-title":"Asbestos and the lung in the 21st century: an update","volume":"8","author":"Yates","year":"2014","journal-title":"Clin Respir J"},{"key":"2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbests-related diseases","volume":"34","author":"Lemen","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. European Respiratory Society\/European Society of Thoracic Surgeons Task Force","volume":"35","author":"de Vuyst","year":"2010","journal-title":"Eur Respir J"},{"key":"4","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajpath.2012.12.028","article-title":"New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas","volume":"182","author":"Hassan","year":"2013","journal-title":"Am J Pathol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Ruffie","year":"2003","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","article-title":"Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies","volume":"34","author":"Sterman","year":"2013","journal-title":"Clin Chest Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/13543784.2013.816281","article-title":"Therapies currently in Phase II trials for malignant pleural mesothelioma","volume":"22","author":"Mutti","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"8","first-page":"1677","article-title":"Inhibition of activated phosphatidylinositol 3-kinase\/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest","volume":"24","author":"Shimizu","year":"2010","journal-title":"Oncol Rep"},{"key":"9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma","volume":"18","author":"Yang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2005.02.010","article-title":"Recent advances in the protein kinase B signaling pathway","volume":"17","author":"Woodgett","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbation of the AKT signaling pathway in human cancer","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","article-title":"Activation of AKT kinases in cancer: implication for therapeutic targeting","volume":"94","author":"Testa","year":"2005","journal-title":"Adv Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4161\/cc.8.16.9335","article-title":"The Akt kinases: isoform specificity in metabolism and cancer","volume":"8","author":"McGraw","year":"2009","journal-title":"Cell Cycle"},{"key":"14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B\u03b1","volume":"7","author":"Reese","year":"1997","journal-title":"Curr Biol"},{"key":"15","first-page":"21920","article-title":"Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation","volume":"27","author":"Roth","year":"1996","journal-title":"J Biol Chem"},{"key":"16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sabatini","year":"2005","journal-title":"Science"},{"key":"17","first-page":"ra46","article-title":"The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy","volume":"4","author":"Parekh","year":"2011","journal-title":"Sci Signal"},{"key":"18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrm1616","article-title":"Calorie restriction, SIRT1 and metabolism: Understanding longevity","volume":"6","author":"Guarente","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: Insights into their biological function","volume":"404","author":"Sinclair","year":"2007","journal-title":"Biochem J"},{"key":"20","doi-asserted-by":"crossref","first-page":"e2020","DOI":"10.1371\/journal.pone.0002020","article-title":"The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth","volume":"3","author":"Campbell","year":"2008","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7150\/ijbs.5.147","article-title":"SIRT1, is it a tumor promoter or tumor suppressor?","volume":"5","author":"Deng","year":"2009","journal-title":"Int J Biol Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1073\/pnas.211430998","article-title":"AKT plays a central role in tumorigenesis","volume":"98","author":"Bellacosa","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Mills","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2353\/ajpath.2009.080721","article-title":"Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis","volume":"174","author":"Catania","year":"2009","journal-title":"Am J Pathol"},{"key":"25","first-page":"205","article-title":"FoxM1 regulates Sirt1 expression in glioma cells","volume":"18","author":"Li","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11684-012-0228-0","article-title":"Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance","volume":"6","author":"Lam","year":"2012","journal-title":"Front Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"28","doi-asserted-by":"crossref","first-page":"e36856","DOI":"10.1371\/journal.pone.0036856","article-title":"Perifosine as a potential novel anti-cancer agent inhibits EGFR\/MET-AKT axis in malignant pleural mesothelioma","volume":"7","author":"Moro","year":"2012","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-08-4523","article-title":"Estrogen receptor-beta affects the prognosis of human malignant mesothelioma","volume":"69","author":"Fennell","year":"2009","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"25121","DOI":"10.18632\/oncotarget.4486","article-title":"Intracellular lactate-mediated induction of estrogen receptor beta (ER\u03b2) in biphasic malignant pleural mesothelioma cells","volume":"6","author":"Daga","year":"2015","journal-title":"Oncotarget"},{"key":"31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)81883-8","article-title":"PI3K: Downstream AKTion blocks apoptosis","volume":"88","author":"Cantley","year":"1997","journal-title":"Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Cantley","year":"2007","journal-title":"Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"36443","DOI":"10.1074\/jbc.M600788200","article-title":"Opposing roles for Akt1 and Akt2 in Rac\/Pak signaling and cell migration","volume":"281","author":"Field","year":"2006","journal-title":"J Biol Chem"},{"key":"34","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI24726","article-title":"Akt1\/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis","volume":"115","author":"Shibata","year":"2005","journal-title":"J Clin Invest"},{"key":"35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cellsig.2013.03.019","article-title":"Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells","volume":"25","author":"Rodriguez-Ubreva","year":"2013","journal-title":"Cell Signal"},{"key":"36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrurol.2013.53","article-title":"Role of oestrogen receptors in bladder cancer development","volume":"10","author":"Yeh","year":"2013","journal-title":"Nat Rev Urol"},{"key":"37","first-page":"196","article-title":"Overexpression of AKT2\/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Ayala","year":"2003","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/era.10.62","article-title":"Nonhistone protein acetylation as cancer therapy targets","volume":"10","author":"Jiang","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2012.06762.x","article-title":"Janus-faced role of SIRT1 in tumorigenesis","volume":"1271","author":"Surh","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1947601912475079","article-title":"The Roles of SIRT1 in Cancer","volume":"4","author":"Fang","year":"2013","journal-title":"Genes Cancer"},{"key":"41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrc3539","article-title":"Forkhead box proteins: tuning forks for transcriptional harmony","volume":"13","author":"Koo","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Lam","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1593\/neo.04277","article-title":"Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data","volume":"6","author":"Gr\u00fctzmann","year":"2004","journal-title":"Neoplasia"},{"key":"44","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ajpath.2011.05.052","article-title":"ER\u03b21 represses FOXM1 expression through targeting ER\u03b1 to control cell proliferation in breast cancer","volume":"179","author":"Ho","year":"2011","journal-title":"Am J Pathol"},{"key":"45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1476-4598-13-227","article-title":"Agonist activation of estrogen receptor beta (ER\u03b2) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity","volume":"13","author":"Nilsson","year":"2014","journal-title":"Molecular Cancer"},{"key":"46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/1541-7786.MCR-06-0245","article-title":"Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein","volume":"5","author":"Smith","year":"2007","journal-title":"Mol Cancer Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/pmic.200600712","article-title":"Proteomic characterization of copper stress response in Cannabis sativa roots","volume":"7","author":"Berta","year":"2007","journal-title":"Proteomics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:18:09Z","timestamp":1589206689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3,22]]}},"alternative-id":["7321","26885609"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7321","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]}}}